Perceptive Xontogeny
1 round tracked since 30 September 2025.
- Rounds
- 1
- Led
- 0
- Capital in these rounds
- $205M
Rounds
- Crystalys TherapeuticsDeveloper of dotinurad, an oral URAT1 blocker for gout $205MSeries A · 30 Sept
No round matches these filters.
1 round tracked since 30 September 2025.
No round matches these filters.